Literature DB >> 27257086

Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.

Anthony W H Chan1, Charing C N Chong2, Frankie K F Mo3, John Wong2, Winnie Yeo3, Philip J Johnson4, Shuangni Yu5, Paul B S Lai2,6, Anthony T C Chan3, Ka-Fai To1,6,7, Stephen L Chan3,6.   

Abstract

BACKGROUND AND AIMS: The albumin-bilirubin (ALBI) grade is a recently emerging alternative of the Child-Pugh (CP) grade. The Cancer of the Liver Italian Program (CLIP) was demonstrated to be a useful prognostic model for hepatocellular carcinoma (HCC) in large prospective cohorts. We aimed to investigate the feasibility of substituting the CP grade by the ALBI grade in the CLIP system and compare the prognostic performance with other existing staging systems.
METHODS: A large cohort of 1973 Chinese patients with HCC was recruited to evaluate the prognostic performance of CP-based CLIP (CP-CLIP) and ALBI-based CLIP (ALBI-CLIP) systems and nine other staging systems by homogeneity likelihood chi-square, c-index, and corrected Akaike information criterion.
RESULTS: The ALBI-CLIP system provided comparable prognostic performance than the CP-CLIP system, which was indicated by homogeneity likelihood chi-squares (ALBI-CLIP 1186.35 vs CP-CLIP 1145.54), c-indices (ALBI-CLIP 0.789 vs CP-CLIP 0.785) and AICs (ALBI-CLIP 15 493.47 vs CP-CLIP 15 534.28). Among 11 staging systems, ALBI-CLIP and CP-CLIP systems were associated with the highest homogeneity chi-squares and c-indices, and the lowest corrected Akaike information criterion. Patients in ALBI-CLIP score 0-4 had better median survival than those in corresponding CP-CLIP score.
CONCLUSIONS: The ALBI grade performs as well as the CP grade when integrating into the CLIP system. ALBI-CLIP and CP-CLIP systems are the most accurate prognostic models among 11 existing staging systems.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Cancer of the Liver Italian Program (CLIP); Child-Pugh; albumin; bilirubin; liver function; prognosis; survival; tumor staging

Mesh:

Substances:

Year:  2017        PMID: 27257086     DOI: 10.1111/jgh.13457

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

2.  Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.

Authors:  Atsushi Hiraoka; Takashi Kumada; Masatoshi Kudo; Masashi Hirooka; Kunihiko Tsuji; Ei Itobayashi; Kazuya Kariyama; Toru Ishikawa; Kazuto Tajiri; Hironori Ochi; Toshifumi Tada; Hidenori Toyoda; Kazuhiro Nouso; Kouji Joko; Hideki Kawasaki; Yoichi Hiasa; Kojiro Michitaka
Journal:  Liver Cancer       Date:  2017-03-09       Impact factor: 11.740

3.  An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study.

Authors:  Ming-Hao Xu; Bin Xu; Chen-Hao Zhou; Zhong Xue; Zhao-Shuo Chen; Wen-Xin Xu; Cheng Huang; Xiao-Dong Zhu; Jian Zhou; Jia Fan; Hui-Chuan Sun; Ying-Hao Shen
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

4.  Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal.

Authors:  Li Li; Xiaomi Li; Wendong Li; Jinglong Chen; Wei Li; Xiaoyan Ding; Yongchao Zhang
Journal:  BMC Cancer       Date:  2022-07-09       Impact factor: 4.638

Review 5.  Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients.

Authors:  Atsushi Hiraoka; Takashi Kumada; Kojiro Michitaka; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2018-11-29       Impact factor: 11.740

6.  Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

Authors:  Atsushi Hiraoka; Kojiro Michitaka; Takashi Kumada; Namiki Izumi; Masumi Kadoya; Norihiro Kokudo; Shoji Kubo; Yutaka Matsuyama; Osamu Nakashima; Michiie Sakamoto; Tadatoshi Takayama; Takashi Kokudo; Kosuke Kashiwabara; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2017-09-22       Impact factor: 11.740

7.  RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.

Authors:  Heng-Yuan Hsu; Ming-Chin Yu; Chao-Wei Lee; Hsin-I Tsai; Chang-Mu Sung; Chun-Wei Chen; Shu-Wei Huang; Cheng-Yu Lin; Wen-Juei Jeng; Wei-Chen Lee; Miin-Fu Chen
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

8.  Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion' '.

Authors:  Iman Waked; Philip J Johnson
Journal:  Br J Cancer       Date:  2017-08-03       Impact factor: 7.640

9.  Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma.

Authors:  Homan Mohammadi; Yazan Abuodeh; William Jin; Jessica Frakes; Mark Friedman; Benjamin Biebel; Junsung Choi; Ghassan El-Haddad; Bela Kis; Jennifer Sweeney; Sarah Hoffe
Journal:  J Gastrointest Oncol       Date:  2018-10

10.  Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma.

Authors:  Stephen Lam Chan; Lin-Lee Wong; Kwan-Chee Allen Chan; Chit Chow; Joanna Hung-Man Tong; Terry Cheuk-Fung Yip; Grace Lai-Hung Wong; Charing Ching-Ning Chong; Po-Hong Liu; Cheuk-Man Chu; Vincent Wai-Sun Wong; Ka-Fai To; Helen L Reeves; Anthony Wing-Hung Chan
Journal:  Liver Cancer       Date:  2019-11-21       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.